Advertisement

Topics

MorphoSys Presents Updated Phase 2 Clinical Results for MOR208 Monotherapy in NHL at ASCO Annual Meeting

12:57 EDT 1 Jun 2015 | GlobalNewsWire (2014)

This article has expired, however you can still download the PDF.
Preview:
MorphoSys AG / MorphoSys Presents Updated Phase 2 Clinical Results for MOR208 Monotherapy in NHL at ASCO Annual Meeting . Processed and transmitted by NASDAQ OMX Corporate Solutions. The issuer is solely responsible for the content of this announcement. ...

Other Sources for this Article

NEXT ARTICLE

More From BioPortfolio on "MorphoSys Presents Updated Phase 2 Clinical Results for MOR208 Monotherapy in NHL at ASCO Annual Meeting"

Advertisement
Quick Search
Advertisement
Advertisement